Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF versus TAF effects on proximal small intestine in treated HIV-positive adults
2022-000849-32Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate and tenofovir alafenamide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Helsinki University Hospital. Started Mar 2022; status: completed.
02
Drugs
tenofovir disoproxil fumaratetenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2022-000849-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000849-32.